MedTrace Logo

Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological and Workplace Outcomes

NCT07534683 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2026-05-14

No results posted yet for this study

Summary

Employees commonly experience stress and reduced well-being that can affect workplace functioning. This interventional study will evaluate whether combining mindfulness-related educational materials with a brief daily guided meditation practice delivered through a smartphone application improves psychological well-being and workplace outcomes compared with educational materials alone. Adult employees will be randomized to receive the meditation plus educational materials during the initial intervention period or after a waitlist period, with assessments completed at multiple time points over approximately 12 weeks. The primary outcome will evaluate change in work engagement using the Utrecht Work Engagement Scale (UWES-9).

Conditions

  • Workplace Wellbeing

Interventions

BEHAVIORAL

Meditation

Participants engage in a minimum of 7 minutes of daily guided meditation via the Miracle of Mind program, delivered through the 3C's app, during their assigned intervention period (Weeks 1-4 for the intervention group; Weeks 5-8 for the waitlist control group). The practice involves voice-guided seated meditation with simple breathing techniques and chants. App- and email-based reminders are provided during the active intervention period only.

BEHAVIORAL

Mindful Educational Material

Participants receive access to work-related mindfulness educational materials throughout the full 12-week study period via the 3C's app. Materials are derived from Sadhguru's teachings and address topics including stress management, communication, and work-life balance. Both groups receive these materials to ensure comparable engagement and provide a control condition for evaluating the specific effects of meditation.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-12-01
Completion
2027-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07534683 on ClinicalTrials.gov